Annual accounts
Small accounts
30/06/2026Filing deadline
Made up to 30/09/2024Due 30/06/2026
- Next accounts made up to
- 30/09/2025
- Last accounts made up to
- 30/09/2024
C3 BIOTECHNOLOGIES LIMITED
Active- 09620994Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- 20 Mannin Way Lancaster Business Park, Caton Road, Lancaster, Lancashire LA1 3SW
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Small
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 10/07/2026View PDF (1 pages)
Cessation of Michael Hyde Smith as a person with significant control on 2026-07-01
- 10/07/2026View PDF (1 pages)
Cessation of Michael Hyde Smith as a person with significant control on 2026-07-01
- 07/07/2026View PDF (3 pages)
Resolutions
- 02/07/2026View PDF (2 pages)
Appointment of Mr Michael Hyde Smith as a director on 2026-07-02
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
87 days overdue
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 03/06/2026
- Last statement dated
- 30/09/2024
Financial performance
The latest figures C3 BIOTECHNOLOGIES LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£405.82K2025
-8.13%vs 20242024: £441.75K
Total Assets
£617.02K2025
-21.88%vs 20242024: £789.78K
Cash in Bank
£97.09K2025
-39.34%vs 20242024: £160.06K
Total Liabilities
£185.22K2025
-33.70%vs 20242024: £279.37K
Employees
112025
+4vs 20242024: 7
Of the 4 measures with an earlier filing to compare against, 4 fell. Total assets moved furthest, down 21.88% on 2024. See the full financial analysis for C3 BIOTECHNOLOGIES LIMITED.
The full financial record
Four ways through C3 BIOTECHNOLOGIES LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · -17.1% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 11 | +4 |
| 2024 | 7 | +2 |
| 2023 | 5 | -1 |
| 2022 | 6 | -1 |
| 2021 | 7 | – |
Reported employee count increased from 7 in 2021 to 11 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
3Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 12/08/2015–02/07/2026 | 7 | |
| Director | 02/07/2026–Present | 11 | |
| Director | 03/06/2015–24/06/2026 | 11 |
Persons with significant control
5Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 25/04/2016–Present | 7 | |
| 04/06/2016–Present | 7 | |
| 24/04/2016–24/04/2016 | 7 | |
| 25/04/2016–Present | 7 | |
| 04/06/2016–Present | 7 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 7 Since 19/05/2026
- Last 12 months
- 7
- Most recent filing
- 10/07/2026 2 months ago
What changed in the last year
- Officer changes (4)Latest 10/07/2026
- Share capitalLatest 19/06/2026
- Accounts filedLatest 19/05/2026
Filing timeline
- 10/07/2026View PDF (1 pages)
Cessation of Michael Hyde Smith as a person with significant control on 2026-07-01
- 10/07/2026View PDF (1 pages)
Cessation of Michael Hyde Smith as a person with significant control on 2026-07-01
- 07/07/2026View PDF (3 pages)
Resolutions
- 02/07/2026View PDF (2 pages)
Appointment of Mr Michael Hyde Smith as a director on 2026-07-02
- 02/07/2026View PDF (1 pages)
Termination of appointment of Nigel Scrutton as a director on 2026-07-02
- 19/06/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-06-18
- 19/05/2026View PDF (11 pages)
Accounts for a small company made up to 2025-09-30
See when the next accounts and confirmation statement are due
Similar companies
40 UK companies are similar to C3 BIOTECHNOLOGIES LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
LINICAL UK LIMITED
ActiveMeacher-Jones, 6 St John's Court, Vicars Lane, Chester, Cheshire CH1 1QE
- Activity
- Research and experimental development on biotechnology
- Company no.
- 09318613
- Incorporated
- 19/11/2014
- Employees
- 13
BIOCORTEX LTD
Active167-169 Great Portland Street, London W1W 5PF
- Activity
- Research and experimental development on biotechnology
- Company no.
- 13287534
- Incorporated
- 23/03/2021
- Employees
- 13
LABOUR RESEARCH DEPARTMENT
Active3 St George's Mews, Westminster Bridge Road, London SE1 7JB
- Activity
- Research and experimental development on social sciences and humanities
- Company no.
- 11429402
- Incorporated
- 22/06/2018
- Employees
- 11
ALGAECYTES LIMITED
ActiveCamburgh House, 27 New Dover Road, Canterbury, Kent CT1 3DN
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 07264317
- Incorporated
- 25/05/2010
- Employees
- 13
APPLIED AGI LIMITED
Active1 Friar Street, Reading RG1 1DA
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 12211733
- Incorporated
- 17/09/2019
- Employees
- 14
About C3 BIOTECHNOLOGIES LIMITED
A short description of the company, written from its Companies House record.
C3 BIOTECHNOLOGIES LIMITED is a private limited company registered in the United Kingdom, based in 20 Mannin Way Lancaster Business Park, Caton Road, Lancaster, Lancashire LA1 3SW. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 11 years 3 months.
The register currently records it as active. Its 2025 accounts report net assets of £405.82K and 11 employees. Its accounts are past the filing deadline shown on the registry record.
C3 BIOTECHNOLOGIES LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does C3 BIOTECHNOLOGIES LIMITED do?
Companies House records C3 BIOTECHNOLOGIES LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is C3 BIOTECHNOLOGIES LIMITED still active?
C3 BIOTECHNOLOGIES LIMITED is recorded as active on the Companies House register, and has been on it since 03/06/2015.
What are C3 BIOTECHNOLOGIES LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £405.82K, total assets of £617.02K, cash in bank of £97.09K and total liabilities of £185.22K.
When did C3 BIOTECHNOLOGIES LIMITED last file with Companies House?
The most recent document on the record is dated 10/07/2026: Cessation of Michael Hyde Smith as a person with significant control on 2026-07-01, 2 months ago.
When are C3 BIOTECHNOLOGIES LIMITED's next filings due?
On the current registry record, accounts are due by 30/06/2026, which has passed.
Who runs C3 BIOTECHNOLOGIES LIMITED?
Companies House lists 3 officers (1 currently in post) and 5 people with significant control (4 current).